Charles Schwab Investment Management Inc Harrow Health, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 251,629 shares of HROW stock, worth $9.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

251,629

Previous 85,027 195.94%

Holding current value

$9.82 Million

Previous $1.78 Million 536.99%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$20.85 - $46.47 $3.47 Million - $7.74 Million	166,602 Added 195.94%	251,629 $11.3 Million
Q2 2024 Aug 12, 2024	BUY	$10.0 - $21.64 $31,980 - $69,204	3,198 Added 3.91%	85,027 $1.78 Million
Q4 2023 Feb 06, 2024	BUY	$8.1 - $16.36 $13,745 - $27,762	1,697 Added 2.12%	81,829 $916,000
Q3 2023 Nov 08, 2023	SELL	$14.03 - $22.08 $67,568 - $106,337	-4,816 Reduced 5.67%	80,132 $1.15 Million
Q2 2023 Aug 09, 2023	BUY	$17.37 - $28.08 $676,005 - $1.09 Million	38,918 Added 84.55%	84,948 $1.62 Million
Q1 2023 May 11, 2023	SELL	$13.84 - $21.46 $787,163 - $1.22 Million	-56,876 Reduced 55.27%	46,030 $973,000
Q4 2022 Feb 13, 2023	SELL	$10.28 - $14.78 $226,735 - $325,987	-22,056 Reduced 17.65%	102,906 $1.52 Million
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $462,897 - $767,106	69,296 Added 124.49%	124,962 $1.16 Million
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $17,164 - $24,989	3,606 Added 6.93%	55,666 $382,000
Q3 2020 Nov 13, 2020	SELL	$4.71 - $7.36 $14,097 - $22,028	-2,993 Reduced 5.44%	52,060 $292,000
Q2 2020 Aug 14, 2020	BUY	$3.61 - $6.47 $198,741 - $356,192	55,053 New	55,053 $287,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Harrow Health, Inc. Transaction History